Heterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer - Secondary publication

Yonsei Medical Journal

Volumn 50, Issue 5, 2009, Pages 697-703

  Jung, Wook Huh ^a   Yoon, Ah Park ^b   Kang, Young Lee ^b   Sohn, Seung Kook ^b  

^a Chonnam National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Adenosine triphosphate; Chemotherapy response assay; Colorectal cancer

Indexed keywords

ADENOSINE TRIPHOSPHATE; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IRINOTECAN; OXALIPLATIN; PACLITAXEL;

ADENOSINE TRIPHOSPHATE BASED CHEMOTHERAPY RESPONSE ASSAY; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BIOASSAY; CANCER CHEMOTHERAPY; CELL DEATH; CELL LEVEL; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; TREATMENT RESPONSE;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 70449724756     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2009.50.5.697     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Center Treatment Gtoup, and the Southwest Oncology Group. Ann Intern Med 1998;129:27-35.
3. Liefers GJ, Tollenaar RA. Cancer genetics and their application to individualised medicine. Eur J Cancer 2002;38:872-879 (Pubitemid 34442314)
4. Cortazar P, Johnson BE. Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol 1999;17:1625-1631 (Pubitemid 29220873)
5. Bogden AE, Griffin W, Reich SD, Costanza ME, Cobb WR. Predictive testing with the subrenal capsule assay. Cancer Treat Rev 1984;11 Suppl A:113-124
6. Rozencweig M, Hofmann V, Sanders C, Rombaut W, Früh U, Martz G. In vitro growth of human malignancies in a cloning assay. Recent Results Cancer Res 1984;94:1-7.
7. Tanigawa N, Kern DH, Hikasa Y, Morton DL. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res 1982;42:2159-2164
8. Yamaue H, Tanimura H, Tsunoda T, Tani M, Iwahashi M, Noguchi K, et al. Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay. Eur J Cancer 1991;27:1258-1263
9. Vescio RA, Redfern CH, Nelson TJ, Ugoretz S, Stern PH, Hoffman RM. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc Natl Acad Sci U S A 1987;84:5029-5033
10. Sevin BU, Peng ZL, Perras JP, Ganjei P, Penalver M, Averette HE. Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing. Gynecol Oncol 1988;31:191-204. (Pubitemid 18221349)
11. Petty RD, Sutherland LA, Hunter EM, Cree IA. Comparison of MTT and ATP-based assays for the measurement of viable cell number. J Biolumin Chemilumin 1995;10:29-34.
12. Cree IA, Neale MH, Myatt NE, de Takats PG, Hall P, Grant J, et al. Heterogeneity of chemosensitivity of metastatic cutaneous melanoma. Anticancer Drugs 1999;10:437-444 (Pubitemid 30011976)
13. Cree IA, Kurbacher CM, Untch M, Sutherland LA, Hunter EM, Subedi AM, et al. Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity. Anticancer Drugs 1996;7:630-635 (Pubitemid 26348840)
14. Kawamura H, Ikeda K, Takiyama I, Terashima M. The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer. Eur J Cancer 1997;33:960-966 (Pubitemid 27287051)
15. Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, et al. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer. Gynecol Oncol 2000;77:258-263 (Pubitemid 30317146)
16. Kang SM, Park MS, Chang J, Kim SK, Kim H, Shin DH, et al. A feasibility study of adenosine triphosphate-based chemotherapy response assay (ATP-CRA) as a chemosensitivity test for lung cancer. Cancer Res Treat 2005;37:223-227
17. Whitehouse PA, Knight LA, Di Nicolantonio F, Mercer SJ, Sharma S, Cree IA; Portsmouth Colorectal Cancer Multidisciplinary Team. Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA). Anticancer Drugs 2003;14:369-375
18. Huh JW, Park YA, Sohn SK, Choi SH. In-vitro chemosensitivity test for colorectal cancer using an adenosine-triphosphate-based chemotherapy response assay (ATP-CRA). J Korean Soc Coloproctol 2007;23:172-179
19. Huh JW, Park YA, Jung EJ, Lee KY, Kwon JE, Sohn SK. Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay. J Korean Med Sci 2008;23:916-919
20. Weisenthal LM, Dill PL, Finklestein JZ, Duarte TE, Baker JA, Moran EM. Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms. Cancer Treat Rep 1986;70:1283-1295
21. Bird MC, Bosanquet AG, Gilby ED. In vitro determination of tumour chemosensitivity in haematological malignancies. Hematol Oncol 1985;3:1-10.
22. Nakahara T, Sakaeda T, Nakamura T, Tamura T, Nishioka C, Aoyama N, et al. Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas. Pharm Res 2004;21:406-412
23. Swanton C, Tomlinson I, Downward J. Chromosomal instability, colorectal cancer and taxane resistance. Cell Cycle 2006;5:818-823 (Pubitemid 44145573)
24. Furukawa T, Kubota T, Hoffman RM. Clinical applications of the histoculture drug response assay. Clin Cancer Res 1995;1:305-311
25. Maehara Y, Kusumoto H, Kusumoto T, Anai H, Sugimachi K. Tumor tissue is more sensitive to mitomycin C, carboquone, and aclacinomycin A than is adjacent normal tissue in vitro. J Surg Oncol 1989;40:4-7. (Pubitemid 19039192)
26. Reinhold U, Tilgen W. Chemosensitivity testing in oncology. Heidelberg: Springer-Verlag; 2003. p.108-145
27. Kodera Y, Ito S, Fujiwara M, Mochizuki Y, Ohashi N, Ito Y, et al. In vitro chemosensitivity for paclitaxel, using human gastric carcinoma tissues. Int J Clin Oncol 2006;11:449-453
28. Iwahashi M, Nakamori M, Nakamura M, Noguchi K, Ueda K, Nakatani Y, et al. Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer. Anticancer Res 2005;25:3453-3459 (Pubitemid 41105224)
29. Samson DJ, Seidenfeld J, Ziegler K, Aronson N. Chemotherapy sensitivity and resistance assays: a systematic review. J Clin Oncol 2004;22:3618-3630 (Pubitemid 41103669)
30. Schrag D, Garewal HS, Burstein HJ, Samson DJ, Von Hoff DD, Somerfield MR; ASCO Working Group on Chemotherapy Sensitivity and Resistance Assays. American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays. J Clin Oncol 2004;22:3631-3638
31. Neale MH, Myatt N, Cree IA, Kurbacher CM, Foss AJ, Hungerford JL, et al. Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside. Br J Cancer 1999;79:1487-1493 (Pubitemid 29116809)
32. Ng TY, Ngan HY, Cheng DK, Wong LC. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponce in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples. Gynecol Oncol 2000;76:405-408
33. Moon YW, Choi SH, Kim YT, Sohn JH, Chang J, Kim SK, et al. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer. Cancer 2007;109:1829-1835.
34. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
35. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22:229-237 (Pubitemid 41095086)